pegylated deoxycytidine analogue DFP-14927
Term · Oncology and biomedicine · MLC-T-ONC-015921
A pegylated formulation containing DFP-10917, an analogue of the nucleoside deoxycytidine, with potential antineoplastic activity. Upon administration, the pegylated deoxycytidine analogue DFP-14927 is incorporated into the DNA of rapidly proliferating cells, such as tumor cells, and directly inhibits the activity of DNA polymerase, which results in the inhibition of DNA replication and cell cycle arrest, DNA fragmentation, and tumor cell apoptosis.
| Identifier | MLC-T-ONC-015921 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | polymeric nucleoside analogue DFP-14927; PEGylated DFP-10917 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015921",
"term": "pegylated deoxycytidine analogue DFP-14927",
"field": "Oncology and biomedicine",
"definition": "A pegylated formulation containing DFP-10917, an analogue of the nucleoside deoxycytidine, with potential antineoplastic activity. Upon administration, the pegylated deoxycytidine analogue DFP-14927 is incorporated into the DNA of rapidly proliferating cells, such as tumor cells, and directly inhibits the activity of DNA polymerase, which results in the inhibition of DNA replication and cell cycle arrest, DNA fragmentation, and tumor cell apoptosis.",
"synonyms": [
"polymeric nucleoside analogue DFP-14927",
"PEGylated DFP-10917"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pegylated-deoxycytidine-analogue-dfp-14927/"
}
Record 12,866 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.